Michael Rofael retweetledi

How do you risk stratify candidates for LVADs? Former @MUSChealth AHFTC fellow @Jgrewal_12 led this Multi-Center Evaluation of the HeartMate 3 Risk Score @TheJHLT jhltonline.org/article/S1053-…
While HM3RS was less predictive in non-trial populations, outcomes were still excellent.

English














